Abstract
Introduction
Undernourishment on hospital admission has been considered as risk factor for complications and increased relapse/nonrelapse mortality in hematopoietic stem cell transplantation (HSCT) patients.
Materials and methods
All patients undergoing HSCT are at an increased risk for malnutrition. The changes in these patients affect mainly protein, energy, and micronutrient metabolism. Nutrition support recommendations are now based on the nutritional status of the individual patient, and total parenteral nutrition is no longer indicated for all HSCT patients. As long as it is possible, an oral route should be use in feeding to avoid complications. When total parenteral nutrition (TPN) should be started is one of the most controversial issues. The following indications for TPN are now generally accepted: severe malnutrition at admission (BMI < 18.5) or weight loss > 10% during treatment or impossibility of oral feeding or failing to meet 60–70% of the requirements over 3 days. Specialized nutritional support containing glutamine or immunomodulatory formulas such as arginine, ω3 polyunsaturated fatty acids, purine/pyrimidines (RNA) may be useful.
Result
The complications of TPN are divided into metabolic and those related to central venous catheter. TPN should be progressively decreased while increasing feedings by the oral route. When the patients can cover ≥50% of the daily energy requirements orally (for greater than 5 days), withdrawal of TPN may be appropriate. In patients who have suffered from graft-versus-host disease (GvHD) with intestinal involvement, TPN should be used until the stool volume decreases to <500 ml/day for at least 2 days.
Conclusion
Parenteral nutrition allows better modulation of fluid, electrolytes, and nutrient administration which can be of critical importance when complications such as GvHD or VOD arise.
Similar content being viewed by others
References
Ljungman P, Urbano-Ispizua A, Cavazzana-Calvo M et al (2006) Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant 37:439–449
Gratwohl A, Baldomero H, Frauendorfer K et al (2007) Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation; focus on increasing use of unrelated donors. Bone Marrow Transplant 39:71–87
Muscaritoli M, Grieco G, Capria S et al (2002) Nutritional and metabolic support in patients undergoing bone marrow transplantation. Am J Clin Nutr 75:183–190
Appelbaum FR (2003) The current status of hematopoietic cell transplantation. Annu Rev Med 54:491–512
Le Blanc K, Ringden O, Remberger M (2003) A low body mass index is correlated with poor survival after allogeneic stem cell transplantation. Haematologica 88:1044–1052
White M, Murphy AJ, Hastings Y et al (2005) Nutritional status and energy expenditure in children pre-bone-marrow-transplant. Bone Marrow Transplant 35:775–779
Deeg HJ, Seidel K, Bruemmer B, Pepe MS, Appelbaum FR (1995) Impact of patient weight on non-relapse mortality after marrow transplantation. Bone Marrow Transplant 15:461–468
McDiarmid S (2002) Nutritional support of the patient receiving high-dose therapy with hematopoietic stem cell support. Can Oncol Nurs J 12:102–115
Correia MI, Waitzberg DL (2003) The impact of malnutrition on morbidity, mortality, length of hospital stay and costs evaluated through a multivariate model analysis. Clin Nutr 22:235–239
Tyc VL, Vllelunga L, Mahoney S et al (1995) Nutritional and treatment related characteristics of pediatric oncology patients referred or not referred for nutritional support. Med Pediatr Oncol 25:379–388
Planas M, Puiggros C, Redecillas S (2006) Contribution of nutritional support to fight cancer cachexia. Nutr Hosp 21:27–36
Martin-Salces M, De Paz R, Canales MA et al (2008) Nutritional recommendations in hematopoietic stem cell transplantation. Nutrition 7–8:769–775
Papadopoulou A, Nathavitharana K, Williams MD et al (1996) Diagnosis and clinical associations of zinc depletion following bone marrow transplantation. Arch Dis Child 74:328–331
McDonald GB, Shulman HM, Sullivan KM, Spencer GD (1986) Intestinal and hepatic complications of human bone marrow transplantation, I and II. Gastroenterol 90:460–477 & 770–784
Blijlevens NM, Donelly JP, Pauw D (2000) BE Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transplant 25:1269–1278
Lee JH, Choi SJ, Lee JH et al (2005) Severe metabolic abnormalities after allogeneic hematopietic cell transplantation. Bone Marrow Transplant 35:63–69
Arfons LM, Lazarus HM (2005) Total parenteral nutrition and hematopoietic stem cell transplantation: an expensive placebo? Bone Marrow Transplant 36:281–288
Gomez Alvarez ME (2004) Parenteral nutrition in hematopoietic stem cell transplantation. Farm Hosp 28:116–122
Pegram AA, Kennedy LD (2001) Prevention and treatment of veno-occlusive disease. Ann Pharmacother 35:935–942
Takatsuka H, Takemoto Y, Iwata N et al (2001) Oral eicosapentaenic acid for complications of bone marrow transplantation. Bone Marrow Transplant 28:769–774
Herrmann VM, Petruska PJ (1993) Nutrition support in bone marrow transplant recipients. Nutr Clin Prac 8:19–27
Ja I, Fibbe WE, Zwinderman AH et al (1999) Parenteral nutrition following intensive cytotoxic therapy: an exploratory study on the need for parenteral nutrition after various treatment approaches for haematological malignancies. Bone Marrow Transplant 23:933–939
Mullen JL, Buzby GP, Waldman MT (1979) Prediction of operative morbidity and mortality by the pre-operative nutritional assessment. Surg Forum 30:80–82
Stern JM (2002) Nutritional assessment and management of malabsorption in the hematopoietic stem cell transplant patient. J Am Diet Assoc 102:1812–1816
Kajiume T, Yoshimi S (2000) Nutritional assessment of peripheral blood stem cell transplantation in children. Pediatr Hematol Oncol 17:389–392
Nysom K, Holm K, Michaelsen KF et al (2001) Degree of fatness after allogeneic BMT for childhood leukaemia or lymphoma. Bone Marrow Transplant 27:817–820
Bloch AS (2000) Oncology diet and nutrition. Patient education resource manual. Aspen, Gaithersburg, MD
Charuhas PM (2002) Pediatric hematopoietic stem cell transplantation. In: Hasse JM, Blue LS (eds) Comprehensive guide to transplant nutrition. American Dietetic Association, Chicago, p 226
Lenssen P, Aker SN (2002) Adult hematopoietic stem cell transplantation. In: Hasse JM, Blue LS (eds) Comprehensive guide to transplant nutrition. American Dietetic Association, Chicago, p 123
Duffy VB, Lucchina LA, Bartoshuk LM (2002) Oral sensation and cancer. In: Berger A, Portnoy RK, Weissman DE (eds) Principles and practice of palliative care and supportive oncology, 2nd edn. JB Lippincott, Philadelphia, p 173
Wickman RS, Rehwaldt M, Kefer C et al (1999) Taste changes experienced by patients receiving chemotherapy. Oncol Nurs Forum 26:697
Mattsson T, Arvidison K, Ljungman P et al (1992) Alterations in taste acuity associated with allogeneic bone marrow transplantation. J Oral Pathol & Med 21:33
Epstein JB, Phillips N, Parry J et al (2002) Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 30:785
Mesejo Arizmendi A, Ordonez Gonzalez J, Ortiz Leyba C (2005) Artificial nutrition in hematopoietic stem cell transplantation. Nutr Hosp 2:54–56
Arendsa J, Bodokyb G, Bozzettic F et al (2006) ESPEN guidelines on enteral nutrition: non-surgical oncology. Clin Nutr 25:245–259
Seguy D, Berthon C, Micol JB et al (2006) Enteral feeding and early outcomes of patients undergoing allogeneic stem cell transplantation following myeloablative conditioning. Transplantation 82:835–839
Ulrich H, Pastores SM, Katz DP et al (1996) Parenteral use of medium-chain triglycerides: a reappraisal. Nutrition 12:231–238
Mirtallo J, Canada T, Johnson D et al (2004) Safe practices for practical nutrition. JPEN J Parenter Enteral Nutr 28:S39–70
Rzepecki P, Barzal J, Sarosiek T, Szczylik C (2007) Biochemical indices for the assessment of nutritional status during hematopoietic stem cell transplantation: are they worth using? A single center experience. Bone Marrow Transplant 40:567–72
Schwarzenberg SJ, Weisdorf-Schindele S (2003) Cancer treatment. In: Walker W, Watkins J, Duggan C (eds) Nutrition in pediatrics: basic science and clinical applications, 3rd edn. BC Decker, Hamilton, ON, pp 709–721
Buchman AL, Dubin MD, Moukarzel A et al (1995) Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation. Hepatology 22:1399–1403
Dahlstrom KA, Ament ME, Moukarzel A et al (1990) Low blood and plasma carnitine levels in children receiving long-term parenteral nutrition. J Pediatr Gastroenterol Nutr 11:375–379
Kaufman SS (2002) Prevention of parenteral nutrition associated liver disease in children. Pediatr Transplant 6:37–42
Fredstrom S, Rogosheske J, Gupta P, Burns IJ (1995) Case report: extrapyramidal symptoms in a BMT recipient with hyperintense basal ganglia and elevated manganese. Bone Marrow Transplant 15:989–992
Curis E, Crenn P, Cynober L (2007) Citrulline and the gut. Curr Opin Clin Nutr Metab Care 10:620–626
Murray SM, Pindoria S (2008) Nutrition support for bone marrow transplant patients. The Cochrane Library issue 4:1–60
Ziegler TR, Young LS, Benfell K et al (1992) Clinical and metabolic efficacy of glutamine supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study. Ann Intern Med 116:821–828
Da Gamma Torres HO, Vilela EG, Da Cunha AS et al (2008) Efficacy of glutamine-supplemented parenteral nutrition on short-term survival following allo-SCT: a randomized study. Bone Marrow Transplant 41:1021–1027
Brown SA, Goringe A, Fegan C et al (1998) Parenteral glutamine protects hepatic function during bone marrow transplantation. Bone Marrow Transplant 22:281–284
Barasch A, Peterson DE (2003) Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions. Oral Oncol 39:91–100
Keefe DM, Rassias G, O’Neil L, Gibson R (2007) Severe mucositis: how can nutrition help? Curr Opin Clin Nutr Metab Care 10:627–631
Pytlik R, Benes P, Patorkova M et al (2002) Standardized parenteral alanyl-glutamine dipeptide supplementation is not beneficial in autologous transplant patients: a randomized, double-blind, placebo controlled study. Bone Marrow Transplant 30:953–961
Crowther M, Avenell A, Culligan DJ (2009) Systematic review and meta-analyses of studies of glutamine supplementation in haematopoietic stem cell transplantation. Bone Marrow Transplant. doi:10.1038/bmt.2009.41
Jebb SA, Marcus R, Elia M (1995) A pilot study of oral glutamine supplementation in patients receiving bone marrow transplants. Clinical Nutrition 14:162–165
Schloerb PR, Skikne BS (1999) Oral and parenteral glutamine in bone marrow transplantation: a randomized, double-blind study. J Parenter Enteral Nutr 23:117–22
Aquino VM, Harvey AR, Garvin JH et al (2005) A double blind randomized placebo-controlled study of oral glutamine in the prevention of mucositis in children undergoing hematopoietic stem cell transplantation: a pediatric blood and marrow transplant consortium study. Bone Marrow Transplant 36:611–6
Schick PK, Menon S, Wojenski C (1990) Effects of marine oil-enriched diets on guinea pig megakaryocyte and platelet lipids: effects on thromboxane synthesis and platelet function. Biochim Biophys Acta 1022:49–56
Endres S, Ghorbani R, Kelley VE et al (1989) The effect of dietary supplementation with n-3 polyunsaturated fatty acid on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 320:265–271
Meydani SN, Endres S, Woods MM et al (1991) Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. J Nutr 121:547–555
Terano T, Salmon JA, Moncada S (1984) Biosynthesis and biological activity of leukotrien B5. Prostaglandins 27:217–232
Suchner U, Kuhn KS, Furst P (2000) The scientific basis of immunonutrition. Proc Nutr Soc 59:553–563
Heys SD, Walker LG, Smith I et al (1999) Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials. Ann Surg 229:467–477
Hadjibabaie M, Iravani M, Taghizadeh M et al (2008) Evaluation of nutritional status in patients undergoing hematopoietic SCT. Bone Marrow Transplant 42:469–473
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rzepecki, P., Barzal, J. & Oborska, S. Blood and marrow transplantation and nutritional support. Support Care Cancer 18 (Suppl 2), 57–65 (2010). https://doi.org/10.1007/s00520-009-0730-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-009-0730-3